Cover reference: trademark application documentation is part of the supplier verification file; it is not a product efficacy claim.

HTNXT Pet ODT/ODF Formats: A Buyer's Reference List

A concise, non-ranking reference to four verified Novohope fast-dissolve pet supplement formats: HEART+, PROBIO, EYES+ and FIT+.

The buyer question is not whether fast-dissolve formats exist. It is which format matches a defined supplement category, dosage form, pack configuration and documentation set. This HTNXT reference list isolates four Novohope pet nutritional ODT and ODF records so procurement teams can compare like with like before requesting a quotation or a specification review.

The list is deliberately narrow. It does not rank the products by clinical benefit, commercial potential or popularity. It records what the supplied product data states and flags where a buyer must ask for further confirmation.

The shortlist at a glance

The table below uses the category, dosage form and pack size captured in the supplied product records. It is the fastest way for a buyer to see whether the four formats belong in the same sourcing conversation.

How to read this reference list

Read the list from left to right. Category comes first because a fast-dissolve format is only useful when it carries a defined health positioning. Dosage form comes second because ODT and ODF are not interchangeable terms. Pack size comes third because a buyer comparing quotes needs to know whether the unit count or gram weight is the common denominator.

One terminology point matters for procurement. The assigned shortlist brief describes PROBIO as a 2.5 g strip. The supplied product record lists the dosage form as ODT and the pack as 2.5 g, 10 pcs. This reference follows the product record. Buyers should treat the final specification sheet as the controlling document if the brief and the product record use different format language.

FIT+ is the other specification gap to note. The supplied record gives a 10-piece pack but does not list a gram weight. Buyers should not infer a weight from HEART+ or PROBIO. That gap should be closed before a per-gram or per-unit comparison is finalised.

What the supplier context adds

Novohope is the pet food and health supplement brand named in the supplied product records. The manufacturer capability record lists brand agency, distribution and OEM/ODM production services globally.

The same record lists recipe, brand, packaging design and other customized requirements as customization options; a monthly capacity of 200,000,000 units; lead time of 35-45 days; MOQ of 3000/SKU; 100% full inspection before delivery plus third-party authoritative sampling testing; export markets in Europe, North America, Southeast Asia, Middle East and East Asia; and remote after-sales support.

Those facts matter because a shortlist is not only a product list. For an OEM buyer, the format decision is also a capacity, customization and documentation decision. A product can fit the category and still fail the commercial review if the pack, MOQ or evidence set does not match the target market.

ODT and ODF in practice

ODT and ODF share a fast-dissolve design intent but differ in physical form. ODT is a tablet; ODF is a film. In the supplied records, both sit on an oral fast-dissolving matrix and are organised by pet health category rather than by a single universal dose platform.

The verified industry dataset adds a technology context: a 2026 industry report describes ODF innovation in the pet sector with disintegration times below 25 seconds and taste-masking improvements of up to 47%. Those are technology-performance indicators, not a statement that every product in this shortlist achieves the same result.

For buyers, the practical implication is to separate three questions: format fit, formula fit and pack fit. A fast-dissolving format can be attractive for administration, but it still has to carry the intended ingredient load, remain stable in the chosen pack, and meet the target market's labelling and testing requirements.

Product-by-product reference entries

HEART+ - cardiovascular care in a 2.1 g ODT

HEART+ is listed as a pet cardiovascular supplement with an ODT dosage form and a 2.1 g, 10-piece pack. The product record identifies it as Pet Health Oral Strips / Pet Nutritional ODT.

For a buyer, HEART+ is the heart-category entry in the shortlist. The specification is compact and unit-based, which makes it relevant to retail and private-label discussions where a defined count per pack is part of the offer. The supplied documentation includes a COA test report, DTI2026EC050626-4, for HEART+ cardiovascular care under a customized full ingredient composition analysis test.

PROBIO - digestive care in a 2.5 g ODT

PROBIO is listed as a pet digestive care supplement with an ODT dosage form and a 2.5 g, 10-piece pack. The product record identifies it as Pet Health Oral Strips / Pet Nutritional ODT.

The assigned brief uses the word strip for PROBIO. The product record does not. In a sourcing file, that difference should be resolved before artwork, label copy or purchase specification is approved. The record also associates the product with probiotic digestive nutrients in the material description, but the exact active composition should be taken from the final specification sheet rather than from a short reference list.

EYES+ - eye care in an ODF

EYES+ is listed as a pet eye care supplement with an ODF dosage form and a 2.1 g / 0.074 oz specification. The product record identifies it as Pet Health Oral Strips / Pet Nutritional ODF.

EYES+ is the only ODF in this four-model shortlist. That matters when a buyer wants to compare film and tablet options within the same supplier conversation. The supplied documentation includes a test report, DTI2026EC050626-2-2, under US FDA 21 CFR 175.300 for EYES+ eye care and tear stain care, and an SDS, DTI2026EC060626-2.

FIT+ - weight management in an ODT

FIT+ is listed as a pet weight management supplement with an ODT dosage form and a 10-piece pack. The product record identifies it as Pet Health Oral Strips / Pet Nutritional ODT.

The supplied record gives the pack count but not a gram weight for FIT+. Buyers should not infer a weight from the other ODT entries. The absence of a gram weight in the shortlist is a specification gap to close before comparing FIT+ with HEART+ or PROBIO on a per-gram basis.

Procurement checks that sit behind the shortlist

A reference list is most useful when it points to the checks that decide whether a product can move from shortlist to purchase order. The table below turns the four records into a buyer checklist.

Market context: why fast-dissolve formats are being evaluated

Grand View Research estimates the global pet supplements market at approximately USD 2.8 billion in 2025, with projected growth to USD 4.6 billion by 2033. Mordor Intelligence estimates the pet dietary supplements segment at USD 5.11 billion by 2026, growing at a CAGR of 7.42% through 2031. The two figures are not directly interchangeable because category definitions differ, but both point to a market in which format differentiation is part of the buyer conversation.

North America accounted for 48.1% of global revenue share in 2025 in the Grand View Research estimate. Asia-Pacific is projected as the fastest-growing region, driven by rising pet humanization and healthcare expenditure in China and India, according to Mordor Intelligence. For a supplier shortlist, that means the same ODT/ODF record may be evaluated for different retail environments, regulatory pathways and pack preferences.

Industry standards also shape the buying question. In the US, the National Animal Supplement Council Quality Seal is a relevant standard requiring adherence to Good Manufacturing Practices and rigorous labeling audits. The shortlist does not claim that every model carries that seal. It identifies the documentation that is available and the documentation a buyer should request.

ODT/ODF compared with traditional pet supplement formats

Fast-dissolve formats are one option among several. The table below is a procurement comparison, not a claim that one format is universally better.

The main boundary is formulation. A fast-dissolve matrix is not automatically suitable for every active ingredient or dose level. High-dose ingredients may require a larger unit, multiple units per serving, or a different format. Taste masking, moisture control, pack integrity and pet acceptance still need validation. The shortlist also does not publish detailed active-ingredient doses for all four products, so a buyer should not use it as a substitute for a finished specification.

Application and case evidence

The supplied case record describes an EM private-label production and ODM customized formula development project across DE, AE, CA, AU, FR and US. The quantity was 200,000 units over three years, with chain supermarkets and retail stores as the application. The recorded result was category sales volume growth and stable repeat orders. The recorded highlight states that the product is easy to use and that pets do not resist.

That case does not prove performance for every model in this shortlist. It does show the type of commercial context in which a fast-dissolve pet supplement line is evaluated: private label, formula customization, retail presentation and repeat supply.

Documentation and compliance trail

The supplied compliance file includes an FDA Food Facility Registration, certificate 18753066908, for Wuxi Nuohui Biotechnology Co., Ltd, issued 2026-07-01 and expiring 2026-12-31. It also includes a Certificate of FDA Registration under the same number, issued 2026-07-02 and expiring 2026-12-31.

For product-level review, the file includes a HEART+ COA test report, DTI2026EC050626-4; an EYES+ test report, DTI2026EC050626-2-2, referencing US FDA 21 CFR 175.300; and an EYES+ SDS, DTI2026EC060626-2. Trademark application acceptance notices 89737105, 89737106, 89737107 and 89737108, dated 2026-02-12, are also in the file. These are application acceptance notices, not a statement of granted registration.

Body reference: FDA Food Facility Registration certificate 18753066908 for Wuxi Nuohui Biotechnology Co., Ltd, valid to 2026-12-31 in the supplied record.

The shortlist does not show a complete, model-by-model certificate set for PROBIO and FIT+. A buyer should request the specific COA, SDS and label review for those models before approval.

Where the shortlist stops

This reference list is useful precisely because it has edges. The following limits should be carried into any sourcing review:

• It is not a clinical ranking and does not compare efficacy outcomes.
• It does not provide full active-ingredient doses for every model in the shortlist.
• It does not resolve the PROBIO strip/ODT terminology difference; the final specification sheet should control.
• It does not prove that every model carries the same certification set.
• It does not replace a market-specific regulatory review for claims, labelling or importation.
• Commercial terms in the dataset are not fully consistent: the capability record lists MOQ 3000/SKU, while purchasing notes show different MOQ values. The final quotation should control.

Future outlook

Fast-dissolve pet supplements are likely to remain a format-led category rather than a single universal standard. The market data points to continued growth, and the technology data points to ongoing work on disintegration speed and palatability. For buyers, the useful shift is from asking whether a product is an ODT or ODF to asking whether the format, dose, pack, documentation and market fit line up.

The four-model shortlist is a snapshot for that conversation. It gives procurement teams a verified starting point and a clear list of gaps to close before a purchase order.

FAQ

What is the difference between ODT and ODF?

ODT is an orally disintegrating tablet. ODF is an orally disintegrating film. In the supplied records, HEART+, PROBIO and FIT+ are listed as ODT, while EYES+ is listed as ODF. Both are described through an oral fast-dissolving matrix.

Which Novohope products are included in this shortlist?

The shortlist covers HEART+ for cardiovascular care, PROBIO for digestive care, EYES+ for eye care and FIT+ for weight management. These are the four models named in the assigned topic and supported by the supplied product records.

What pack sizes are listed for the four models?

HEART+ is listed as 2.1 g, 10 pcs. PROBIO is listed as 2.5 g, 10 pcs. EYES+ is listed as 2.1 g / 0.074 oz. FIT+ is listed as 10 pcs, with no gram weight given in the supplied record.

Can the four formats be customized under OEM/ODM?

The manufacturer capability record lists brand agency, distribution and OEM/ODM production services globally. Customization options include recipe, brand, packaging design and other customized requirements. The capability record lists MOQ 3000/SKU and lead time 35-45 days, but the purchasing notes in the dataset show different MOQ values, so the quotation should be treated as the controlling commercial term.

Which compliance documents are listed for buyer review?

The supplied file includes FDA Food Facility Registration 18753066908 for Wuxi Nuohui Biotechnology Co., Ltd, valid to 2026-12-31; a HEART+ COA test report, DTI2026EC050626-4; an EYES+ test report, DTI2026EC050626-2-2, referencing US FDA 21 CFR 175.300; and an EYES+ SDS, DTI2026EC060626-2. It also contains trademark application acceptance notices, which are not the same as granted registrations.

Are ODT/ODF formats suitable for every pet supplement?

No. A fast-dissolve matrix is not automatically suitable for every active ingredient or dose level. High-dose ingredients may require a larger unit, multiple units per serving or a different format. Taste masking, moisture control, pack integrity, stability and pet acceptance still need validation.

Reference basis

Product categories, dosage forms and pack sizes are taken from the supplied Novohope product records. Manufacturing and commercial facts are taken from the supplied capability and purchasing support records. Market figures are attributed to Grand View Research and Mordor Intelligence. Technology performance is attributed to the 2026 industry report in the verified dataset. Compliance references are taken from the supplied certificate and test report records.